Market Overview

UPDATE: JP Morgan Initiates Health Management Associates at Neutral on Near Term Uncertainty

Share:
Related HMA
Benzinga's Volume Movers
US Stock Futures Rise Ahead Of International Trade Data

JP Morgan initiated coverage on Health Management Associates (NYSE: HMA) with a Neutral rating and a $9 price target.

JP Morgan commented, "Although reform should provide a solid boost, HMA offers relatively less upside potential from reform-based coverage expansion when compared to its peers according to our JPM Healthcare Reform Model. When this more modest EBITDA upside versus peers (~8% vs. ~10% group average) is coupled with company specific headline risks related to government investigations into admission practices and the potential for this to negatively impact future volumes as well as M&A prospects, we see HMA as a comparatively less attractive name in the group."

Health Management Associates closed at $8.28 on Monday.

Latest Ratings for HMA

DateFirmActionFromTo
Dec 2013Wells FargoDowngradesOutperformMarket Perform
Sep 2013Avondale PartnersDowngradesMarket OutperformMarket Perform
Aug 2013UBSDowngradesBuyNeutral

View More Analyst Ratings for HMA
View the Latest Analyst Ratings

Posted-In: JP MorganAnalyst Color Price Target Pre-Market Outlook Analyst Ratings

 

Related Articles (HMA)

Around the Web, We're Loving...

Get Benzinga's Newsletters